financetom
Business
financetom
/
Business
/
Manufacturing GE engines, high-altitude drones opens new tech horizon for India: Bharat Forge CMD
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Manufacturing GE engines, high-altitude drones opens new tech horizon for India: Bharat Forge CMD
Jun 21, 2023 11:14 AM

Defence firm Bharat Forge Ltd on Wednesday, June 21, said manufacturing of GE-F414 engines and high-altitude drones by General Atomics will open up a new technology that was closed to India. The US administration had approved a deal between General Electric and Hindustan Aeronautics Ltd (HAL) to co-manufacture F414 jet engines in India.

Share Market Live

NSE

Also, India had approved the procurement of 30 MQ-9B Predator armed drones from the US under a government-to-government framework.

Speaking exclusively to CNBC-TV18, Baba Kalyani, Bharat Forge Chairman And Managing Director, said the ‘Atmanirbhar’ process that Prime Minister Modi has unleashed in India will create fantastic opportunities for India's industry.

He said the historic state visit of PM Modi to the US, pre-discussions that were held in India during the CEO Forum in March, ICET meeting that happened a few weeks ago, have completely opened up a new orbit for Indian business and industry, with Washington D.C.

"When you are talking about jet engines for fighter jets, normally there is something like 300-350 different technologies that are used in making jet engines. Important among them are single crystal blades, and high technology forgings that are required in a jet engine. We hope to be a part of that," Kalyani said.

He noted that the jet engines deal is going to be a large space for industry to participate in this programme as one company alone can't do everything by itself. “So I think there will be a huge opportunity and huge horizontal deployment of these technologies as the technology comes into India through this transfer of jet engine technology to HAL,” he said.

In January this year, San Diego-based General Atomics Aeronautical Systems (GA-ASI), a subsidiary of General Atomics, announced a partnership with Bharat Forge to manufacture main landing gear components, subassemblies, and assemblies of remotely piloted aircraft in the country.

(Edited by : Shoma Bhattacharjee)

First Published:Jun 21, 2023 8:14 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: ShaMaran Closes Transaction to Increase Its Working Interest in the Atrush Block in Iraq's Kurdistan Region
Update: ShaMaran Closes Transaction to Increase Its Working Interest in the Atrush Block in Iraq's Kurdistan Region
Aug 7, 2024
11:49 AM EDT, 08/07/2024 (MT Newswires) -- ShaMaran Petroleum ( SHASF ) on Wednesday said it closed the acquisition of TAQA Atrush and the subsequent sale of an indirect interest in Atrush to HKN Energy IV. The two-step transaction announced in January increased ShaMaran's 28% indirect stake in the Atrush oil block in Iraq's Kurdistan region to a 50% working...
Update: KITS Eyecare Up 3.4% as It Swings to Q2 Profit as Revenue Hits a Record High
Update: KITS Eyecare Up 3.4% as It Swings to Q2 Profit as Revenue Hits a Record High
Aug 7, 2024
11:45 AM EDT, 08/07/2024 (MT Newswires) -- KITS Eyecare ( KTYCF ) on Wednesday said it swung to a profit in the second-quarter as revenue jumped 26% to a record. The on-line eyeglasses company said its second-quarter came in at $187,000, or $0.01 per share, swinging from a loss of $1.2 million, or $0.04, in the year-prior period. Revenue rose...
Takeda Wins European Commission's Approval for Adzynma to Treat Blood Clotting Disorder
Takeda Wins European Commission's Approval for Adzynma to Treat Blood Clotting Disorder
Aug 7, 2024
11:45 AM EDT, 08/07/2024 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) said Wednesday it received approval from the European Commission for Adzynma for the treatment of congenital thrombotic thrombocytopenic purpura, a rare blood clotting disorder caused by a deficiency in the ADAMTS13 enzyme. Takeda said the EC approval does not have any impact on its consolidated forecast for the...
Vaccine Maker Emergent BioSolutions Expects Deeper Losses In 2024, Stock Sinks
Vaccine Maker Emergent BioSolutions Expects Deeper Losses In 2024, Stock Sinks
Aug 7, 2024
On Tuesday, Emergent BioSolutions Inc. ( EBS ) reported second-quarter 2024 sales of $254.7 million, down 25% year over year, beating the consensus of $190 million. The company reported an adjusted EPS loss of $(2.32), more than double the $(1.05) reported a year ago, missing the consensus of $(0.94). Revenues from Narcan (naloxone HCl) Nasal Spray decreased 10% to $120 million, primarily...
Copyright 2023-2026 - www.financetom.com All Rights Reserved